Verrica Pharmaceuticals (VRCA) PT Lowered to $18 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Oren Livnat lowered the price target on Verrica Pharmaceuticals (NASDAQ: VRCA) to $18.00 (from $24.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
